Lipiodol-I-131의 경간동맥 주입에 의한 간암치료의 가능성에 관한 연구 ( Therapeutic Feasibility Study and Clinical Trial of Intrahepatic I-131-Lipiodol on Patients with Hepatocellular Carcinoma ) () |
Author |
유형식(Hyung Sik Yoo),서정호(Jung Ho Suh),이종태(Jong Tae Lee),김동익(Dong Ik Kim),박창윤(Chang Yun Park),김병수(Byung Soo Kim),박찬희(Chan H. Park),M.Thakur, |
|
Affiliation |
|
Abstract |
An iodized oil such as Ethiodol or Lipiodol was
selectively retained in the tumor vessels of the large
hepatomas as well as in the small daughter hepatomas
for long periods following the intra-arterial hepatic
injection of such contrast material. The specific aim
of the study is to deliver a high internal radiation
dose to hepatocellular car- cinoma (HCC) in an attempt
to control the disease. We were able to replace a sma11
fraction of the stable iodine (I-127) of the 37% iodine
in Lipioclol by the I ' with 100% exehange efficiency.
I ' labeled Lipiodol was injected through the super-
selerted tumor feeding artery under superselection or
into the proper hepatic arterial level of patients who
have malignant hepatomas confirmed by aspiration
cytology, serum AFP and various imaging modalities,
Clinica! traial was performed on 43 cases during recent
6 months and follow-up observa- tion was carried out.
No severe complications or other adverse reactions were
encountered until nowdays. I"'"-Lipiodol was stable in
vivo and no significant activity was noted in the
".hyroid, stomach, blood and urine after the
injection. Only small fraction of radioisotope activity
was noticed in the both side of lungs. Tumor to normal
liver radio was very high. Therefore, 1 '-Lipiodol (or
P-32-Lipiodol) will be effective delivering high
internal radiation dose to the tumor while delivering
small radiation doses to normal tisaues. Labeling,
tumor dose caiculation and preliminary findings will be
presented. |
Keyword |
|
Full text Article |
28500680.pdf
|
|
|